In a 12-year-old girl with spirometry showing forced vital capacity 63% of predicted, forced expiratory volume in one second 82% of predicted, and FEV1/FVC ratio 72%, is asthma likely?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Asthma is Unlikely Based on This Spirometry Pattern

This 12-year-old girl's spirometry results do NOT suggest asthma. The pattern shows a restrictive defect (low FVC at 63% predicted) with a preserved FEV1/FVC ratio of 72%, which is inconsistent with the obstructive airflow limitation that characterizes asthma 1.

Why This Pattern Argues Against Asthma

Spirometry Interpretation

According to the 2021 European Respiratory Society guidelines for diagnosing asthma in children aged 5-16 years, abnormal spirometry suggestive of asthma requires either:

  • FEV1/FVC ratio below the lower limit of normal (LLN) or <80%, OR
  • FEV1 below LLN or <80% predicted 1

This patient's values:

  • FVC: 63% predicted (markedly reduced)
  • FEV1: 82% predicted (borderline normal)
  • FEV1/FVC: 72% (preserved ratio, though slightly reduced)

The key issue here is that while the FEV1/FVC ratio is mildly reduced at 72%, this occurs in the context of a severely reduced FVC (63%). This pattern suggests a restrictive process, not the obstructive pattern typical of asthma 2.

Critical Distinction: Restrictive vs. Obstructive Pattern

In asthma, you expect:

  • Reduced FEV1/FVC ratio (typically <80% or below LLN)
  • Normal or near-normal FVC with disproportionately reduced FEV1
  • Reversibility with bronchodilator (≥12% and/or ≥200 mL improvement in FEV1) 1

This patient shows:

  • Severely reduced FVC (63% predicted) - the primary abnormality
  • Relatively preserved FEV1 (82% predicted)
  • Mildly reduced FEV1/FVC ratio as a mathematical consequence of low FVC, not true obstruction

Recommended Diagnostic Approach

Immediate Next Steps

  1. Perform bronchodilator reversibility (BDR) testing - This is essential to determine if there is any reversible airflow obstruction 1

    • Positive BDR: ≥12% AND/OR ≥200 mL improvement in FEV1 or FVC
    • If BDR is negative with this pattern, asthma becomes even less likely
  2. Measure FeNO (fractional exhaled nitric oxide) 1

    • FeNO ≥25 ppb would suggest eosinophilic airway inflammation
    • FeNO <25 ppb makes asthma unlikely
  3. Investigate the restrictive pattern - A severely reduced FVC (63% predicted) requires evaluation for:

    • Poor spirometry technique (most common in children)
    • Chest wall abnormalities
    • Neuromuscular conditions
    • Interstitial lung disease
    • Obesity
    • Prior lung injury

Important Caveats

The ERS guidelines emphasize that at least two abnormal objective tests are required to diagnose asthma in children 1. A single abnormal spirometry result, especially one showing a restrictive rather than obstructive pattern, is insufficient for diagnosis.

Normal spirometry does not exclude asthma 1, but this patient doesn't have normal spirometry - she has an abnormal pattern that is inconsistent with typical asthma physiology.

If Strong Clinical Suspicion Persists

If symptoms strongly suggest asthma despite these findings:

  • Repeat spirometry when symptomatic 1
  • Consider bronchial challenge testing (methacholine or exercise challenge) if BDR and FeNO are negative 1
  • Monitor peak expiratory flow rate (PEFR) variability - ≥12% variability supports asthma 1

What NOT to Do

Do not start empiric asthma treatment based on symptoms alone 1. The guidelines explicitly recommend against using symptomatic improvement with inhaled corticosteroids as a diagnostic criterion. Objective testing must confirm the diagnosis.

Bottom Line

This spirometry pattern (low FVC with preserved FEV1/FVC ratio) represents a restrictive defect, not the obstructive pattern characteristic of asthma. Before considering asthma, ensure proper spirometry technique, perform BDR testing and FeNO measurement, and investigate alternative causes for the restrictive pattern. The diagnosis of asthma requires at least two abnormal objective tests demonstrating variable expiratory airflow limitation 1.

Related Questions

What is the cutoff FEV1 (Forced Expiratory Volume in 1 second)/FVC (Forced Vital Capacity) ratio to diagnose asthma?
With a forced expiratory volume in one second (FEV1) of 52% predicted and a forced vital capacity ratio (FEV1/FVC) of 111% predicted, does this suggest asthma?
How should I use the FEV1/FVC ratio to diagnose asthma and guide its management?
Given an FEV1/FVC ratio of 78% (within normal range) with mildly reduced forced vital capacity and a bronchodilator response showing a 12% and 200 mL increase in forced expiratory volume in 1 second, what is the most likely diagnosis and appropriate treatment plan?
What do the lung function results (FEV1 55% predicted, vital capacity 62% predicted, total lung capacity 59% predicted) indicate?
How should I interpret spirometry results showing forced vital capacity 63% of predicted, forced expiratory volume in one second 82% of predicted, and FEV1/FVC ratio 72%, and what are the next diagnostic steps?
What is the recommended management of lower extremity edema in a patient taking ibrutinib (Imbruvica)?
What is the best selective serotonin reuptake inhibitor (SSRI) for a 17-year-old patient with anxiety and depression?
What are the appropriate BiPAP (bilevel positive airway pressure) settings and explanations for a stable COPD patient with a resting PaCO₂ of approximately 60 mm Hg?
Which test—functional fibrinogen activity (Clauss method) or antigenic fibrinogen level—is more appropriate for assessing bleeding risk?
What broad-spectrum oral antibiotic is appropriate for a patient on dialysis, and what is the recommended dosing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.